Home ➤ Life Science ➤ Healthcare ➤ Analgesics Market
Analgesics Market
Published date: Nov 2024 • Formats:
Request Sample Schedule a Call

Global Analgesics Market Analysis By Drug Class [Opioids (Morphine, Fentanyl, Codiene, Methadone, Meperidine, Oxycodone, Tramadol, Dextromethorphan, Buprenorphine, Others), NSAIDs, Local Anesthetics, Acetaminophen], By Indication (Surgical Pain, Cancer Pain, Neuropathic Pain, Others), By Type (Prescription, OTC), By Route of Administration (Oral, Parenteral, Transdermal, Others), By Distribution Channel (Hospital pharmacies, Retail pharmacies, Online pharmacies), By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033

  • Published date: Nov 2024
  • Report ID: 134003
  • Number of Pages: 276
  • Format:
  • keyboard_arrow_up
    • 1. Executive Summary
      • 1.1. Definition
      • 1.2. Market Snapshot
      • 1.3. Market Overview
      • 1.4. Segment Overview
      • 1.5. Regional Overview
      • 1.6. Competitive Landscape
      • 1.7. Taxonomy
    • 2. Global Market Overview
      • 2.1. Global Market Insights and Industry Overview
      • 2.2. Market Dynamics
        • 2.2.1. Drivers
        • 2.2.2. Restraints
        • 2.2.3. Opportunities
        • 2.2.4. Key Analgesics Market Trends
      • 2.3. Regulatory Framework
      • 2.4. Opportunity Map Analysis
      • 2.5. Opportunity Orbits
      • 2.6. PESTLE Analysis
      • 2.7. PORTER’S Five Force Analysis
      • 2.8. Drivers & Restraints Impact Analysis
      • 2.9. Value Chain Analysis
        • 2.9.1. List of Raw Materials Suppliers
        • 2.9.2. List of Analgesics Manufacturers
        • 2.9.3. List of Dealer/Distributors
      • 2.10. Regional Market Share and BPS Analysis
      • 2.11. Impact of Macro-economic Factors/Geopolitical Factors
    • 3. Global Analgesics Market Analysis and Forecast, By Segment, 2019-2033
      • 3.1. Key Findings
      • 3.2. Global Analgesics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Drug Class, 2019-2033
      • 3.3. Global Analgesics Market Attractiveness Analysis, By Drug Class
        • 3.3.1. Opioids
          • 3.3.1.1. Insights
          • 3.3.1.2. Key Takeaways
            • 3.3.1.2.1. Morphine
            • 3.3.1.2.2. Fentanyl
            • 3.3.1.2.3. Codiene
            • 3.3.1.2.4. Methadone
            • 3.3.1.2.5. Meperidine
            • 3.3.1.2.6. Oxycodone
            • 3.3.1.2.7. Tramadol
            • 3.3.1.2.8. Dextromethorphan
            • 3.3.1.2.9. Buprenorphine
            • 3.3.1.2.10. Others
        • 3.3.2. NSAIDs
          • 3.3.2.1. Insights
          • 3.3.2.2. Key Takeaways
        • 3.3.3. Local Anesthetics
          • 3.3.3.1. Insights
          • 3.3.3.2. Key Takeaways
        • 3.3.4. Acetaminophen
          • 3.3.4.1. Insights
          • 3.3.4.2. Key Takeaways
      • 3.4. Global Analgesics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Type, 2019-2033
      • 3.5. Global Analgesics Market Attractiveness Analysis, By Type
        • 3.5.1. Prescription
          • 3.5.1.1. Insights
          • 3.5.1.2. Key Takeaways
        • 3.5.2. OTC
          • 3.5.2.1. Insights
          • 3.5.2.2. Key Takeaways
      • 3.6. Global Analgesics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Indication, 2019-2033
      • 3.7. Global Analgesics Market Attractiveness Analysis, By Indication
        • 3.7.1. Surgical Pain
          • 3.7.1.1. Insights
          • 3.7.1.2. Key Takeaways
        • 3.7.2. Cancer Pain
          • 3.7.2.1. Insights
          • 3.7.2.2. Key Takeaways
        • 3.7.3. Neuropathic Pain
          • 3.7.3.1. Insights
          • 3.7.3.2. Key Takeaways
        • 3.7.4. Others
          • 3.7.4.1. Insights
          • 3.7.4.2. Key Takeaways
      • 3.8. Global Analgesics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Route of Administration, 2019-2033
      • 3.9. Global Analgesics Market Attractiveness Analysis, By Route of Administration
        • 3.9.1. Oral
          • 3.9.1.1. Insights
          • 3.9.1.2. Key Takeaways
        • 3.9.2. Parenteral
          • 3.9.2.1. Insights
          • 3.9.2.2. Key Takeaways
        • 3.9.3. Transdermal
          • 3.9.3.1. Insights
          • 3.9.3.2. Key Takeaways
        • 3.9.4. Others
          • 3.9.4.1. Insights
          • 3.9.4.2. Key Takeaways
      • 3.10. Global Analgesics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2019-2033
      • 3.11. Global Analgesics Market Attractiveness Analysis, By Distribution Channel
        • 3.11.1. Hospital pharmacies
          • 3.11.1.1. Insights
          • 3.11.1.2. Key Takeaways
        • 3.11.2. Retail pharmacies
          • 3.11.2.1. Insights
          • 3.11.2.2. Key Takeaways
        • 3.11.3. Online pharmacies
          • 3.11.3.1. Insights
          • 3.11.3.2. Key Takeaways
    • 4. Global Analgesics Market Analysis and Forecast, By Region, 2019-2033
      • 4.1. Key Findings
      • 4.2. Global Analgesics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Region, 2019-2033
        • 4.2.1. North America
          • 4.2.1.1. Regional Insights
        • 4.2.2. Europe
          • 4.2.2.1. Regional Insights
        • 4.2.3. Asia Pacific
          • 4.2.3.1. Regional Insights
        • 4.2.4. Latin America
          • 4.2.4.1. Regional Insights
        • 4.2.5. Middle East & Africa
          • 4.2.5.1. Regional Insights
      • 4.3. Global Analgesics Market Attractiveness Analysis, By Region
    • 5. North America Analgesics Market Analysis and Forecast, 2019-2033
      • 5.1. Key Findings
      • 5.2. North America Analgesics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Drug Class, 2019-2033
      • 5.3. North America Analgesics Market Attractiveness Analysis, By Drug Class
      • 5.4. North America Analgesics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Type, 2019-2033
      • 5.5. North America Analgesics Market Attractiveness Analysis, By Type
      • 5.6. North America Analgesics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Indication, 2019-2033
      • 5.7. North America Analgesics Market Attractiveness Analysis, By Indication
      • 5.8. North America Analgesics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Route of Administration, 2019-2033
      • 5.9. North America Analgesics Market Attractiveness Analysis, By Route of Administration
      • 5.10. North America Analgesics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2019-2033
      • 5.11. North America Analgesics Market Attractiveness Analysis, By Distribution Channel
      • 5.12. North America Analgesics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2019-2033
      • 5.13. North America Analgesics Market Attractiveness Analysis, By Country
        • 5.13.1. The US
        • 5.13.2. Canada
    • 6. Europe Analgesics Market Analysis and Forecast, 2019-2033
      • 6.1. Key Findings
      • 6.2. Europe Analgesics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Drug Class, 2019-2033
      • 6.3. Europe Analgesics Market Attractiveness Analysis, By Drug Class
      • 6.4. Europe Analgesics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Type, 2019-2033
      • 6.5. Europe Analgesics Market Attractiveness Analysis, By Type
      • 6.6. Europe Analgesics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Indication, 2019-2033
      • 6.7. Europe Analgesics Market Attractiveness Analysis, By Indication
      • 6.8. Europe Analgesics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Route of Administration, 2019-2033
      • 6.9. Europe Analgesics Market Attractiveness Analysis, By Route of Administration
      • 6.10. Europe Analgesics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2019-2033
      • 6.11. Europe Analgesics Market Attractiveness Analysis, By Distribution Channel
      • 6.12. Europe Analgesics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2019-2033
      • 6.13. Europe Analgesics Market Attractiveness Analysis, By Country
        • 6.13.1. Germany
        • 6.13.2. The UK
        • 6.13.3. France
        • 6.13.4. Spain
        • 6.13.5. Italy
        • 6.13.6. Russia
        • 6.13.7. Netherland
        • 6.13.8. Rest of Europe
    • 7. Asia Pacific Analgesics Market Analysis and Forecast, 2019-2033
      • 7.1. Key Findings
      • 7.2. Asia Pacific Analgesics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Drug Class, 2019-2033
      • 7.3. Asia Pacific Analgesics Market Attractiveness Analysis, By Drug Class
      • 7.4. Asia Pacific Analgesics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Type, 2019-2033
      • 7.5. Asia Pacific Analgesics Market Attractiveness Analysis, By Type
      • 7.6. Asia Pacific Analgesics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Indication, 2019-2033
      • 7.7. Asia Pacific Analgesics Market Attractiveness Analysis, By Indication
      • 7.8. Asia Pacific Analgesics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Route of Administration, 2019-2033
      • 7.9. Asia Pacific Analgesics Market Attractiveness Analysis, By Route of Administration
      • 7.10. Asia Pacific Analgesics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2019-2033
      • 7.11. Asia Pacific Analgesics Market Attractiveness Analysis, By Distribution Channel
      • 7.12. Asia Pacific Analgesics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2019-2033
      • 7.13. Asia Pacific Analgesics Market Attractiveness Analysis, By Country
        • 7.13.1. China
        • 7.13.2. Japan
        • 7.13.3. South Korea
        • 7.13.4. India
        • 7.13.5. Australia
        • 7.13.6. New Zealand
        • 7.13.7. Singapore
        • 7.13.8. Thailand
        • 7.13.9. Vietnam
        • 7.13.10. Rest of Asia Pacific
    • 8. Latin America Analgesics Market Analysis and Forecast, 2019-2033
      • 8.1. Key Findings
      • 8.2. Latin America Analgesics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Drug Class, 2019-2033
      • 8.3. Latin America Analgesics Market Attractiveness Analysis, By Drug Class
      • 8.4. Latin America Analgesics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Type, 2019-2033
      • 8.5. Latin America Analgesics Market Attractiveness Analysis, By Type
      • 8.6. Latin America Analgesics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Indication, 2019-2033
      • 8.7. Latin America Analgesics Market Attractiveness Analysis, By Indication
      • 8.8. Latin America Analgesics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Route of Administration, 2019-2033
      • 8.9. Latin America Analgesics Market Attractiveness Analysis, By Route of Administration
      • 8.10. Latin America Analgesics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2019-2033
      • 8.11. Latin America Analgesics Market Attractiveness Analysis, By Distribution Channel
      • 8.12. Latin America Analgesics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2019-2033
      • 8.13. Latin America Analgesics Market Attractiveness Analysis, By Country
        • 8.13.1. Brazil
        • 8.13.2. Mexico
        • 8.13.3. Rest of Latin America
    • 9. Middle East & Africa Analgesics Market Analysis and Forecast, 2019-2033
      • 9.1. Key Findings
      • 9.2. Middle East & Africa Analgesics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Drug Class, 2019-2033
      • 9.3. Middle East & Africa Analgesics Market Attractiveness Analysis, By Drug Class
      • 9.4. Middle East & Africa Analgesics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Type, 2019-2033
      • 9.5. Middle East & Africa Analgesics Market Attractiveness Analysis, By Type
      • 9.6. Middle East & Africa Analgesics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Indication, 2019-2033
      • 9.7. Middle East & Africa Analgesics Market Attractiveness Analysis, By Indication
      • 9.8. Middle East & Africa Analgesics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Route of Administration, 2019-2033
      • 9.9. Middle East & Africa Analgesics Market Attractiveness Analysis, By Route of Administration
      • 9.10. Middle East & Africa Analgesics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2019-2033
      • 9.11. Middle East & Africa Analgesics Market Attractiveness Analysis, By Distribution Channel
      • 9.12. Middle East & Africa Analgesics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2019-2033
      • 9.13. Middle East & Africa Analgesics Market Attractiveness Analysis, By Country
        • 9.13.1. South Africa
        • 9.13.2. Saudi Arabia
        • 9.13.3. UAE
        • 9.13.4. Rest of Middle East & Africa
    • 10. Competitive Landscape & Company Profiles
      • 10.1. Market Competition Scenario Analysis, By Company
        • 10.1.1. Key Takeaways
      • 10.2. Overview of Major Market Players
      • 10.3. Competitor Landscape
      • 10.4. Strategic Mapping
      • 10.5. Company Life Cycle Analysis
      • 10.6. Company Market Share Analysis
      • 10.7. Company Profiles
        • 10.7.1. Abbott
          • 10.7.1.1. Company Details
          • 10.7.1.2. Business Overview
          • 10.7.1.3. Product Portfolio
          • 10.7.1.4. Financial Insights
          • 10.7.1.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.1.6. SWOT Analysis
          • 10.7.1.7. Geographic Footprint
        • 10.7.2. Pfizer Inc.
          • 10.7.2.1. Company Details
          • 10.7.2.2. Business Overview
          • 10.7.2.3. Product Portfolio
          • 10.7.2.4. Financial Insights
          • 10.7.2.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.2.6. SWOT Analysis
          • 10.7.2.7. Geographic Footprint
        • 10.7.3. Eli Lilly & Company
          • 10.7.3.1. Company Details
          • 10.7.3.2. Business Overview
          • 10.7.3.3. Product Portfolio
          • 10.7.3.4. Financial Insights
          • 10.7.3.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.3.6. SWOT Analysis
          • 10.7.3.7. Geographic Footprint
        • 10.7.4. Endo International plc
          • 10.7.4.1. Company Details
          • 10.7.4.2. Business Overview
          • 10.7.4.3. Product Portfolio
          • 10.7.4.4. Financial Insights
          • 10.7.4.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.4.6. SWOT Analysis
          • 10.7.4.7. Geographic Footprint
        • 10.7.5. F. Hoffmann-La Roche AG
          • 10.7.5.1. Company Details
          • 10.7.5.2. Business Overview
          • 10.7.5.3. Product Portfolio
          • 10.7.5.4. Financial Insights
          • 10.7.5.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.5.6. SWOT Analysis
          • 10.7.5.7. Geographic Footprint
        • 10.7.6. Bausch Health Companies Inc.
          • 10.7.6.1. Company Details
          • 10.7.6.2. Business Overview
          • 10.7.6.3. Product Portfolio
          • 10.7.6.4. Financial Insights
          • 10.7.6.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.6.6. SWOT Analysis
          • 10.7.6.7. Geographic Footprint
        • 10.7.7. Merck & Co. Inc.
          • 10.7.7.1. Company Details
          • 10.7.7.2. Business Overview
          • 10.7.7.3. Product Portfolio
          • 10.7.7.4. Financial Insights
          • 10.7.7.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.7.6. SWOT Analysis
          • 10.7.7.7. Geographic Footprint
        • 10.7.8. AbbVie Inc.
          • 10.7.8.1. Company Details
          • 10.7.8.2. Business Overview
          • 10.7.8.3. Product Portfolio
          • 10.7.8.4. Financial Insights
          • 10.7.8.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.8.6. SWOT Analysis
          • 10.7.8.7. Geographic Footprint
        • 10.7.9. Novartis AG
          • 10.7.9.1. Company Details
          • 10.7.9.2. Business Overview
          • 10.7.9.3. Product Portfolio
          • 10.7.9.4. Financial Insights
          • 10.7.9.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.9.6. SWOT Analysis
          • 10.7.9.7. Geographic Footprint
        • 10.7.10. Johnson & Johnson
          • 10.7.10.1. Company Details
          • 10.7.10.2. Business Overview
          • 10.7.10.3. Product Portfolio
          • 10.7.10.4. Financial Insights
          • 10.7.10.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.10.6. SWOT Analysis
          • 10.7.10.7. Geographic Footprint
        • 10.7.11. GSK plc.
          • 10.7.11.1. Company Details
          • 10.7.11.2. Business Overview
          • 10.7.11.3. Product Portfolio
          • 10.7.11.4. Financial Insights
          • 10.7.11.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.11.6. SWOT Analysis
          • 10.7.11.7. Geographic Footprint
        • 10.7.12. Purdue Pharma L.P.
          • 10.7.12.1. Company Details
          • 10.7.12.2. Business Overview
          • 10.7.12.3. Product Portfolio
          • 10.7.12.4. Financial Insights
          • 10.7.12.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.12.6. SWOT Analysis
          • 10.7.12.7. Geographic Footprint
        • 10.7.13. Sun Pharmaceutical Industries Ltd
          • 10.7.13.1. Company Details
          • 10.7.13.2. Business Overview
          • 10.7.13.3. Product Portfolio
          • 10.7.13.4. Financial Insights
          • 10.7.13.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.13.6. SWOT Analysis
          • 10.7.13.7. Geographic Footprint
        • 10.7.14. Sanofi
          • 10.7.14.1. Company Details
          • 10.7.14.2. Business Overview
          • 10.7.14.3. Product Portfolio
          • 10.7.14.4. Financial Insights
          • 10.7.14.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.14.6. SWOT Analysis
          • 10.7.14.7. Geographic Footprint
    • 11. Methodology and Data Source
      • 11.1. Methodology/Research Approach
      • 11.2. Market Size Estimation
      • 11.3. Market Breakdown and Data Triangulation
      • 11.4. Data Source
      • 11.5. Secondary Sources
      • 11.6. Primary Sources
      • 11.7. Appendix
      • 11.8. Disclaimer
    • List of Tables
      • Table 1. Global Analgesics Market Value (US$ Mn), By Drug Class, 2019-2033
      • Table 2. Global Analgesics Market Value (US$ Mn), By Type, 2019-2033
      • Table 3. Global Analgesics Market Value (US$ Mn), By Indication, 2019-2033
      • Table 4. Global Analgesics Market Value (US$ Mn), By Route of Administration, 2019-2033
      • Table 5. Global Analgesics Market Value (US$ Mn), By Distribution Channel, 2019-2033
      • Table 6. Global Analgesics Market Value (US$ Mn), By Region, 2019-2033
      • Table 7. North America Analgesics Market Value (US$ Mn), By Drug Class, 2019-2033
      • Table 8. North America Analgesics Market Value (US$ Mn), By Type, 2019-2033
      • Table 9. North America Analgesics Market Value (US$ Mn), By Indication, 2019-2033
      • Table 10. North America Analgesics Market Value (US$ Mn), By Route of Administration, 2019-2033
      • Table 11. North America Analgesics Market Value (US$ Mn), By Distribution Channel, 2019-2033
      • Table 12. North America Analgesics Market Value (US$ Mn), By Country, 2019-2033
      • Table 13. The US Analgesics Market Value (US$ Mn), By Drug Class, 2019-2033
      • Table 14. The US Analgesics Market Value (US$ Mn), By Type, 2019-2033
      • Table 15. The US Analgesics Market Value (US$ Mn), By Indication, 2019-2033
      • Table 16. The US Analgesics Market Value (US$ Mn), By Route of Administration, 2019-2033
      • Table 17. The US Analgesics Market Value (US$ Mn), By Distribution Channel, 2019-2033
      • Table 18. Canada Analgesics Market Value (US$ Mn), By Drug Class, 2019-2033
      • Table 19. Canada Analgesics Market Value (US$ Mn), By Type, 2019-2033
      • Table 20. Canada Analgesics Market Value (US$ Mn), By Indication, 2019-2033
      • Table 21. Canada Analgesics Market Value (US$ Mn), By Route of Administration, 2019-2033
      • Table 22. Canada Analgesics Market Value (US$ Mn), By Distribution Channel, 2019-2033
      • Table 23. Europe Analgesics Market Value (US$ Mn), By Drug Class, 2019-2033
      • Table 24. Europe Analgesics Market Value (US$ Mn), By Type, 2019-2033
      • Table 25. Europe Analgesics Market Value (US$ Mn), By Indication, 2019-2033
      • Table 26. Europe Analgesics Market Value (US$ Mn), By Route of Administration, 2019-2033
      • Table 27. Europe Analgesics Market Value (US$ Mn), By Distribution Channel, 2019-2033
      • Table 28. Europe Analgesics Market Value (US$ Mn), By Country, 2019-2033
      • Table 29. Germany Analgesics Market Value (US$ Mn), By Drug Class, 2019-2033
      • Table 30. Germany Analgesics Market Value (US$ Mn), By Type, 2019-2033
      • Table 31. Germany Analgesics Market Value (US$ Mn), By Indication, 2019-2033
      • Table 32. Germany Analgesics Market Value (US$ Mn), By Route of Administration, 2019-2033
      • Table 33. Germany Analgesics Market Value (US$ Mn), By Distribution Channel, 2019-2033
      • Table 34. The UK Analgesics Market Value (US$ Mn), By Drug Class, 2019-2033
      • Table 35. The UK Analgesics Market Value (US$ Mn), By Type, 2019-2033
      • Table 36. The UK Analgesics Market Value (US$ Mn), By Indication, 2019-2033
      • Table 37. The UK Analgesics Market Value (US$ Mn), By Route of Administration, 2019-2033
      • Table 38. The UK Analgesics Market Value (US$ Mn), By Distribution Channel, 2019-2033
      • Table 39. France Analgesics Market Value (US$ Mn), By Drug Class, 2019-2033
      • Table 40. France Analgesics Market Value (US$ Mn), By Type, 2019-2033
      • Table 41. France Analgesics Market Value (US$ Mn), By Indication, 2019-2033
      • Table 42. France Analgesics Market Value (US$ Mn), By Route of Administration, 2019-2033
      • Table 43. France Analgesics Market Value (US$ Mn), By Distribution Channel, 2019-2033
      • Table 44. Spain Analgesics Market Value (US$ Mn), By Drug Class, 2019-2033
      • Table 45. Spain Analgesics Market Value (US$ Mn), By Type, 2019-2033
      • Table 46. Spain Analgesics Market Value (US$ Mn), By Indication, 2019-2033
      • Table 47. Spain Analgesics Market Value (US$ Mn), By Route of Administration, 2019-2033
      • Table 48. Spain Analgesics Market Value (US$ Mn), By Distribution Channel, 2019-2033
      • Table 49. Italy Analgesics Market Value (US$ Mn), By Drug Class, 2019-2033
      • Table 50. Italy Analgesics Market Value (US$ Mn), By Type, 2019-2033
      • Table 51. Italy Analgesics Market Value (US$ Mn), By Indication, 2019-2033
      • Table 52. Italy Analgesics Market Value (US$ Mn), By Route of Administration, 2019-2033
      • Table 53. Italy Analgesics Market Value (US$ Mn), By Distribution Channel, 2019-2033
      • Table 54. Russia Analgesics Market Value (US$ Mn), By Drug Class, 2019-2033
      • Table 55. Russia Analgesics Market Value (US$ Mn), By Type, 2019-2033
      • Table 56. Russia Analgesics Market Value (US$ Mn), By Indication, 2019-2033
      • Table 57. Russia Analgesics Market Value (US$ Mn), By Route of Administration, 2019-2033
      • Table 58. Russia Analgesics Market Value (US$ Mn), By Distribution Channel, 2019-2033
      • Table 59. Netherland Analgesics Market Value (US$ Mn), By Drug Class, 2019-2033
      • Table 60. Netherland Analgesics Market Value (US$ Mn), By Type, 2019-2033
      • Table 61. Netherland Analgesics Market Value (US$ Mn), By Indication, 2019-2033
      • Table 62. Netherland Analgesics Market Value (US$ Mn), By Route of Administration, 2019-2033
      • Table 63. Netherland Analgesics Market Value (US$ Mn), By Distribution Channel, 2019-2033
      • Table 64. Rest of Europe Analgesics Market Value (US$ Mn), By Drug Class, 2019-2033
      • Table 65. Rest of Europe Analgesics Market Value (US$ Mn), By Type, 2019-2033
      • Table 66. Rest of Europe Analgesics Market Value (US$ Mn), By Indication, 2019-2033
      • Table 67. Rest of Europe Analgesics Market Value (US$ Mn), By Route of Administration, 2019-2033
      • Table 68. Rest of Europe Analgesics Market Value (US$ Mn), By Distribution Channel, 2019-2033
      • Table 69. Asia Pacific Analgesics Market Value (US$ Mn), By Drug Class, 2019-2033
      • Table 70. Asia Pacific Analgesics Market Value (US$ Mn), By Type, 2019-2033
      • Table 71. Asia Pacific Analgesics Market Value (US$ Mn), By Indication, 2019-2033
      • Table 72. Asia Pacific Analgesics Market Value (US$ Mn), By Route of Administration, 2019-2033
      • Table 73. Asia Pacific Analgesics Market Value (US$ Mn), By Distribution Channel, 2019-2033
      • Table 74. Asia Pacific Analgesics Market Value (US$ Mn), By Country, 2019-2033
      • Table 75. China Analgesics Market Value (US$ Mn), By Drug Class, 2019-2033
      • Table 76. China Analgesics Market Value (US$ Mn), By Type, 2019-2033
      • Table 77. China Analgesics Market Value (US$ Mn), By Indication, 2019-2033
      • Table 78. China Analgesics Market Value (US$ Mn), By Route of Administration, 2019-2033
      • Table 79. China Analgesics Market Value (US$ Mn), By Distribution Channel, 2019-2033
      • Table 80. India Analgesics Market Value (US$ Mn), By Drug Class, 2019-2033
      • Table 81. India Analgesics Market Value (US$ Mn), By Type, 2019-2033
      • Table 82. India Analgesics Market Value (US$ Mn), By Indication, 2019-2033
      • Table 83. India Analgesics Market Value (US$ Mn), By Route of Administration, 2019-2033
      • Table 84. India Analgesics Market Value (US$ Mn), By Distribution Channel, 2019-2033
      • Table 85. Japan Analgesics Market Value (US$ Mn), By Drug Class, 2019-2033
      • Table 86. Japan Analgesics Market Value (US$ Mn), By Type, 2019-2033
      • Table 87. Japan Analgesics Market Value (US$ Mn), By Indication, 2019-2033
      • Table 88. Japan Analgesics Market Value (US$ Mn), By Route of Administration, 2019-2033
      • Table 89. Japan Analgesics Market Value (US$ Mn), By Distribution Channel, 2019-2033
      • Table 90. South Korea Analgesics Market Value (US$ Mn), By Drug Class, 2019-2033
      • Table 91. South Korea Analgesics Market Value (US$ Mn), By Type, 2019-2033
      • Table 92. South Korea Analgesics Market Value (US$ Mn), By Indication, 2019-2033
      • Table 93. South Korea Analgesics Market Value (US$ Mn), By Route of Administration, 2019-2033
      • Table 94. South Korea Analgesics Market Value (US$ Mn), By Distribution Channel, 2019-2033
      • Table 95. Australia Analgesics Market Value (US$ Mn), By Drug Class, 2019-2033
      • Table 96. Australia Analgesics Market Value (US$ Mn), By Type, 2019-2033
      • Table 97. Australia Analgesics Market Value (US$ Mn), By Indication, 2019-2033
      • Table 98. Australia Analgesics Market Value (US$ Mn), By Route of Administration, 2019-2033
      • Table 99. Australia Analgesics Market Value (US$ Mn), By Distribution Channel, 2019-2033
      • Table 100. New Zealand Analgesics Market Value (US$ Mn), By Drug Class, 2019-2033
      • Table 101. New Zealand Analgesics Market Value (US$ Mn), By Type, 2019-2033
      • Table 102. New Zealand Analgesics Market Value (US$ Mn), By Indication, 2019-2033
      • Table 103. New Zealand Analgesics Market Value (US$ Mn), By Route of Administration, 2019-2033
      • Table 104. New Zealand Analgesics Market Value (US$ Mn), By Distribution Channel, 2019-2033
      • Table 105. Singapore Analgesics Market Value (US$ Mn), By Drug Class, 2019-2033
      • Table 106. Singapore Analgesics Market Value (US$ Mn), By Type, 2019-2033
      • Table 107. Singapore Analgesics Market Value (US$ Mn), By Indication, 2019-2033
      • Table 108. Singapore Analgesics Market Value (US$ Mn), By Route of Administration, 2019-2033
      • Table 109. Singapore Analgesics Market Value (US$ Mn), By Distribution Channel, 2019-2033
      • Table 110. Thailand Analgesics Market Value (US$ Mn), By Drug Class, 2019-2033
      • Table 111. Thailand Analgesics Market Value (US$ Mn), By Type, 2019-2033
      • Table 112. Thailand Analgesics Market Value (US$ Mn), By Indication, 2019-2033
      • Table 113. Thailand Analgesics Market Value (US$ Mn), By Route of Administration, 2019-2033
      • Table 114. Thailand Analgesics Market Value (US$ Mn), By Distribution Channel, 2019-2033
      • Table 115. Vietnam Analgesics Market Value (US$ Mn), By Drug Class, 2019-2033
      • Table 116. Vietnam Analgesics Market Value (US$ Mn), By Type, 2019-2033
      • Table 117. Vietnam Analgesics Market Value (US$ Mn), By Indication, 2019-2033
      • Table 118. Vietnam Analgesics Market Value (US$ Mn), By Route of Administration, 2019-2033
      • Table 119. Vietnam Analgesics Market Value (US$ Mn), By Distribution Channel, 2019-2033
      • Table 120. Rest of Asia Pacific Analgesics Market Value (US$ Mn), By Drug Class, 2019-2033
      • Table 121. Rest of Asia Pacific Analgesics Market Value (US$ Mn), By Type, 2019-2033
      • Table 122. Rest of Asia Pacific Analgesics Market Value (US$ Mn), By Indication, 2019-2033
      • Table 123. Rest of Asia Pacific Analgesics Market Value (US$ Mn), By Route of Administration, 2019-2033
      • Table 124. Rest of Asia Pacific Analgesics Market Value (US$ Mn), By Distribution Channel, 2019-2033
      • Table 125. Latin America Analgesics Market Value (US$ Mn), By Drug Class, 2019-2033
      • Table 126. Latin America Analgesics Market Value (US$ Mn), By Type, 2019-2033
      • Table 127. Latin America Analgesics Market Value (US$ Mn), By Indication, 2019-2033
      • Table 128. Latin America Analgesics Market Value (US$ Mn), By Route of Administration, 2019-2033
      • Table 129. Latin America Analgesics Market Value (US$ Mn), By Distribution Channel, 2019-2033
      • Table 130. Latin America Analgesics Market Value (US$ Mn), By Country, 2019-2033
      • Table 131. Brazil Analgesics Market Value (US$ Mn), By Drug Class, 2019-2033
      • Table 132. Brazil Analgesics Market Value (US$ Mn), By Type, 2019-2033
      • Table 133. Brazil Analgesics Market Value (US$ Mn), By Indication, 2019-2033
      • Table 134. Brazil Analgesics Market Value (US$ Mn), By Route of Administration, 2019-2033
      • Table 135. Brazil Analgesics Market Value (US$ Mn), By Distribution Channel, 2019-2033
      • Table 136. Mexico Analgesics Market Value (US$ Mn), By Drug Class, 2019-2033
      • Table 137. Mexico Analgesics Market Value (US$ Mn), By Type, 2019-2033
      • Table 138. Mexico Analgesics Market Value (US$ Mn), By Indication, 2019-2033
      • Table 139. Mexico Analgesics Market Value (US$ Mn), By Route of Administration, 2019-2033
      • Table 140. Mexico Analgesics Market Value (US$ Mn), By Distribution Channel, 2019-2033
      • Table 141. Rest of Latin America Analgesics Market Value (US$ Mn), By Drug Class, 2019-2033
      • Table 142. Rest of Latin America Analgesics Market Value (US$ Mn), By Type, 2019-2033
      • Table 143. Rest of Latin America Analgesics Market Value (US$ Mn), By Indication, 2019-2033
      • Table 144. Rest of Latin America Analgesics Market Value (US$ Mn), By Route of Administration, 2019-2033
      • Table 145. Rest of Latin America Analgesics Market Value (US$ Mn), By Distribution Channel, 2019-2033
      • Table 146. Middle East & Africa Analgesics Market Value (US$ Mn), By Drug Class, 2019-2033
      • Table 147. Middle East & Africa Analgesics Market Value (US$ Mn), By Type, 2019-2033
      • Table 148. Middle East & Africa Analgesics Market Value (US$ Mn), By Indication, 2019-2033
      • Table 149. Middle East & Africa Analgesics Market Value (US$ Mn), By Route of Administration, 2019-2033
      • Table 150. Middle East & Africa Analgesics Market Value (US$ Mn), By Distribution Channel, 2019-2033
      • Table 151. Middle East & Africa Analgesics Market Value (US$ Mn), By Country, 2019-2033
      • Table 152. South Africa Analgesics Market Value (US$ Mn), By Drug Class, 2019-2033
      • Table 153. South Africa Analgesics Market Value (US$ Mn), By Type, 2019-2033
      • Table 154. South Africa Analgesics Market Value (US$ Mn), By Indication, 2019-2033
      • Table 155. South Africa Analgesics Market Value (US$ Mn), By Route of Administration, 2019-2033
      • Table 156. South Africa Analgesics Market Value (US$ Mn), By Distribution Channel, 2019-2033
      • Table 157. Saudi Arabia Analgesics Market Value (US$ Mn), By Drug Class, 2019-2033
      • Table 158. Saudi Arabia Analgesics Market Value (US$ Mn), By Type, 2019-2033
      • Table 159. Saudi Arabia Analgesics Market Value (US$ Mn), By Indication, 2019-2033
      • Table 160. Saudi Arabia Analgesics Market Value (US$ Mn), By Route of Administration, 2019-2033
      • Table 161. Saudi Arabia Analgesics Market Value (US$ Mn), By Distribution Channel, 2019-2033
      • Table 162. UAE Analgesics Market Value (US$ Mn), By Drug Class, 2019-2033
      • Table 163. UAE Analgesics Market Value (US$ Mn), By Type, 2019-2033
      • Table 164. UAE Analgesics Market Value (US$ Mn), By Indication, 2019-2033
      • Table 165. UAE Analgesics Market Value (US$ Mn), By Route of Administration, 2019-2033
      • Table 166. UAE Analgesics Market Value (US$ Mn), By Distribution Channel, 2019-2033
      • Table 167. Rest of Middle East & Africa Analgesics Market Value (US$ Mn), By Drug Class, 2019-2033
      • Table 168. Rest of Middle East & Africa Analgesics Market Value (US$ Mn), By Type, 2019-2033
      • Table 169. Rest of Middle East & Africa Analgesics Market Value (US$ Mn), By Indication, 2019-2033
      • Table 170. Rest of Middle East & Africa Analgesics Market Value (US$ Mn), By Route of Administration, 2019-2033
      • Table 171. Rest of Middle East & Africa Analgesics Market Value (US$ Mn), By Distribution Channel, 2019-2033
    • List of Figures
      • Figure 1. Global Analgesics Market Snapshot: Market Value (US$ Mn), 2019-2033
      • Figure 2. Opportunity Map
      • Figure 3. Opportunity Orbit
      • Figure 4. Regional Market Share and BPS Analysis in Analgesics Market
      • Figure 5. Global Analgesics Market Analysis, By Drug Class, 2019, 2023 and 2033
      • Figure 6. Global Analgesics Market Attractiveness Analysis, By Drug Class
      • Figure 7. Global Analgesics Market Analysis, By Type, 2019, 2023 and 2033
      • Figure 8. Global Analgesics Market Attractiveness Analysis, By Type
      • Figure 9. Global Analgesics Market Analysis, By Indication, 2019, 2023 and 2033
      • Figure 10. Global Analgesics Market Attractiveness Analysis, By Indication
      • Figure 11. Global Analgesics Market Analysis, By Route of Administration, 2019, 2023 and 2033
      • Figure 12. Global Analgesics Market Attractiveness Analysis, By Route of Administration
      • Figure 13. Global Analgesics Market Analysis, By Distribution Channel, 2019, 2023 and 2033
      • Figure 14. Global Analgesics Market Attractiveness Analysis, By Distribution Channel
      • Figure 15. Global Analgesics Market Analysis, By Region, 2019, 2023 and 2033
      • Figure 16. Global Analgesics Market Attractiveness Analysis, By Region
      • Figure 17. North America Analgesics Market Analysis, By Drug Class, 2019, 2023 and 2033
      • Figure 18. North America Analgesics Market Attractiveness Analysis, By Drug Class
      • Figure 19. North America Analgesics Market (US$ Mn), by Opioids, 2019-2033
      • Figure 20. North America Analgesics Market (US$ Mn), by NSAIDs, 2019-2033
      • Figure 21. North America Analgesics Market (US$ Mn), by Local Anesthetics, 2019-2033
      • Figure 22. North America Analgesics Market (US$ Mn), by Acetaminophen, 2019-2033
      • Figure 23. North America Analgesics Market Analysis, By Type, 2019, 2023 and 2033
      • Figure 24. North America Analgesics Market Attractiveness Analysis, By Type
      • Figure 25. North America Analgesics Market (US$ Mn), by Prescription, 2019-2033
      • Figure 26. North America Analgesics Market (US$ Mn), by OTC, 2019-2033
      • Figure 27. North America Analgesics Market Analysis, By Indication, 2019, 2023 and 2033
      • Figure 28. North America Analgesics Market Attractiveness Analysis, By Indication
      • Figure 29. North America Analgesics Market (US$ Mn), by Surgical Pain, 2019-2033
      • Figure 30. North America Analgesics Market (US$ Mn), by Cancer Pain, 2019-2033
      • Figure 31. North America Analgesics Market (US$ Mn), by Neuropathic Pain, 2019-2033
      • Figure 32. North America Analgesics Market (US$ Mn), by Others, 2019-2033
      • Figure 33. North America Analgesics Market Analysis, By Route of Administration, 2019, 2023 and 2033
      • Figure 34. North America Analgesics Market Attractiveness Analysis, By Route of Administration
      • Figure 35. North America Analgesics Market (US$ Mn), by Oral, 2019-2033
      • Figure 36. North America Analgesics Market (US$ Mn), by Parenteral, 2019-2033
      • Figure 37. North America Analgesics Market (US$ Mn), by Transdermal, 2019-2033
      • Figure 38. North America Analgesics Market (US$ Mn), by Others, 2019-2033
      • Figure 39. North America Analgesics Market Analysis, By Distribution Channel, 2019, 2023 and 2033
      • Figure 40. North America Analgesics Market Attractiveness Analysis, By Distribution Channel
      • Figure 41. North America Analgesics Market (US$ Mn), by Hospital pharmacies, 2019-2033
      • Figure 42. North America Analgesics Market (US$ Mn), by Retail pharmacies, 2019-2033
      • Figure 43. North America Analgesics Market (US$ Mn), by Online pharmacies, 2019-2033
      • Figure 44. North America Analgesics Market Analysis, By Country, 2019, 2023 and 2033
      • Figure 45. North America Analgesics Market Attractiveness Analysis, By Country
      • Figure 46. Europe Analgesics Market Analysis, By Drug Class, 2019, 2023 and 2033
      • Figure 47. Europe Analgesics Market Attractiveness Analysis, By Drug Class
      • Figure 48. Europe Analgesics Market (US$ Mn), by Opioids, 2019-2033
      • Figure 49. Europe Analgesics Market (US$ Mn), by NSAIDs, 2019-2033
      • Figure 50. Europe Analgesics Market (US$ Mn), by Local Anesthetics, 2019-2033
      • Figure 51. Europe Analgesics Market (US$ Mn), by Acetaminophen, 2019-2033
      • Figure 52. Europe Analgesics Market Analysis, By Type, 2019, 2023 and 2033
      • Figure 53. Europe Analgesics Market Attractiveness Analysis, By Type
      • Figure 54. Europe Analgesics Market (US$ Mn), by Prescription, 2019-2033
      • Figure 55. Europe Analgesics Market (US$ Mn), by OTC, 2019-2033
      • Figure 56. Europe Analgesics Market Analysis, By Indication, 2019, 2023 and 2033
      • Figure 57. Europe Analgesics Market Attractiveness Analysis, By Indication
      • Figure 58. Europe Analgesics Market (US$ Mn), by Surgical Pain, 2019-2033
      • Figure 59. Europe Analgesics Market (US$ Mn), by Cancer Pain, 2019-2033
      • Figure 60. Europe Analgesics Market (US$ Mn), by Neuropathic Pain, 2019-2033
      • Figure 61. Europe Analgesics Market (US$ Mn), by Others, 2019-2033
      • Figure 62. Europe Analgesics Market Analysis, By Route of Administration, 2019, 2023 and 2033
      • Figure 63. Europe Analgesics Market Attractiveness Analysis, By Route of Administration
      • Figure 64. Europe Analgesics Market (US$ Mn), by Oral, 2019-2033
      • Figure 65. Europe Analgesics Market (US$ Mn), by Parenteral, 2019-2033
      • Figure 66. Europe Analgesics Market (US$ Mn), by Transdermal, 2019-2033
      • Figure 67. Europe Analgesics Market (US$ Mn), by Others, 2019-2033
      • Figure 68. Europe Analgesics Market Analysis, By Distribution Channel, 2019, 2023 and 2033
      • Figure 69. Europe Analgesics Market Attractiveness Analysis, By Distribution Channel
      • Figure 70. Europe Analgesics Market (US$ Mn), by Hospital pharmacies, 2019-2033
      • Figure 71. Europe Analgesics Market (US$ Mn), by Retail pharmacies, 2019-2033
      • Figure 72. Europe Analgesics Market (US$ Mn), by Online pharmacies, 2019-2033
      • Figure 73. Europe Analgesics Market Analysis, By Country, 2019, 2023 and 2033
      • Figure 74. Europe Analgesics Market Attractiveness Analysis, By Country
      • Figure 75. Asia Pacific Analgesics Market Analysis, By Drug Class, 2019, 2023 and 2033
      • Figure 76. Asia Pacific Analgesics Market Attractiveness Analysis, By Drug Class
      • Figure 77. Asia Pacific Analgesics Market (US$ Mn), by Opioids, 2019-2033
      • Figure 78. Asia Pacific Analgesics Market (US$ Mn), by NSAIDs, 2019-2033
      • Figure 79. Asia Pacific Analgesics Market (US$ Mn), by Local Anesthetics, 2019-2033
      • Figure 80. Asia Pacific Analgesics Market (US$ Mn), by Acetaminophen, 2019-2033
      • Figure 81. Asia Pacific Analgesics Market Analysis, By Type, 2019, 2023 and 2033
      • Figure 82. Asia Pacific Analgesics Market Attractiveness Analysis, By Type
      • Figure 83. Asia Pacific Analgesics Market (US$ Mn), by Prescription, 2019-2033
      • Figure 84. Asia Pacific Analgesics Market (US$ Mn), by OTC, 2019-2033
      • Figure 85. Asia Pacific Analgesics Market Analysis, By Indication, 2019, 2023 and 2033
      • Figure 86. Asia Pacific Analgesics Market Attractiveness Analysis, By Indication
      • Figure 87. Asia Pacific Analgesics Market (US$ Mn), by Surgical Pain, 2019-2033
      • Figure 88. Asia Pacific Analgesics Market (US$ Mn), by Cancer Pain, 2019-2033
      • Figure 89. Asia Pacific Analgesics Market (US$ Mn), by Neuropathic Pain, 2019-2033
      • Figure 90. Asia Pacific Analgesics Market (US$ Mn), by Others, 2019-2033
      • Figure 91. Asia Pacific Analgesics Market Analysis, By Route of Administration, 2019, 2023 and 2033
      • Figure 92. Asia Pacific Analgesics Market Attractiveness Analysis, By Route of Administration
      • Figure 93. Asia Pacific Analgesics Market (US$ Mn), by Oral, 2019-2033
      • Figure 94. Asia Pacific Analgesics Market (US$ Mn), by Parenteral, 2019-2033
      • Figure 95. Asia Pacific Analgesics Market (US$ Mn), by Transdermal, 2019-2033
      • Figure 96. Asia Pacific Analgesics Market (US$ Mn), by Others, 2019-2033
      • Figure 97. Asia Pacific Analgesics Market Analysis, By Distribution Channel, 2019, 2023 and 2033
      • Figure 98. Asia Pacific Analgesics Market Attractiveness Analysis, By Distribution Channel
      • Figure 99. Asia Pacific Analgesics Market (US$ Mn), by Hospital pharmacies, 2019-2033
      • Figure 100. Asia Pacific Analgesics Market (US$ Mn), by Retail pharmacies, 2019-2033
      • Figure 101. Asia Pacific Analgesics Market (US$ Mn), by Online pharmacies, 2019-2033
      • Figure 102. Asia Pacific Analgesics Market Analysis, By Country, 2019, 2023 and 2033
      • Figure 103. Asia Pacific Analgesics Market Attractiveness Analysis, By Country
      • Figure 104. Latin America Analgesics Market Analysis, By Drug Class, 2019, 2023 and 2033
      • Figure 105. Latin America Analgesics Market Attractiveness Analysis, By Drug Class
      • Figure 106. Latin America Analgesics Market (US$ Mn), by Opioids, 2019-2033
      • Figure 107. Latin America Analgesics Market (US$ Mn), by NSAIDs, 2019-2033
      • Figure 108. Latin America Analgesics Market (US$ Mn), by Local Anesthetics, 2019-2033
      • Figure 109. Latin America Analgesics Market (US$ Mn), by Acetaminophen, 2019-2033
      • Figure 110. Latin America Analgesics Market Analysis, By Type, 2019, 2023 and 2033
      • Figure 111. Latin America Analgesics Market Attractiveness Analysis, By Type
      • Figure 112. Latin America Analgesics Market (US$ Mn), by Prescription, 2019-2033
      • Figure 113. Latin America Analgesics Market (US$ Mn), by OTC, 2019-2033
      • Figure 114. Latin America Analgesics Market Analysis, By Indication, 2019, 2023 and 2033
      • Figure 115. Latin America Analgesics Market Attractiveness Analysis, By Indication
      • Figure 116. Latin America Analgesics Market (US$ Mn), by Surgical Pain, 2019-2033
      • Figure 117. Latin America Analgesics Market (US$ Mn), by Cancer Pain, 2019-2033
      • Figure 118. Latin America Analgesics Market (US$ Mn), by Neuropathic Pain, 2019-2033
      • Figure 119. Latin America Analgesics Market (US$ Mn), by Others, 2019-2033
      • Figure 120. Latin America Analgesics Market Analysis, By Route of Administration, 2019, 2023 and 2033
      • Figure 121. Latin America Analgesics Market Attractiveness Analysis, By Route of Administration
      • Figure 122. Latin America Analgesics Market (US$ Mn), by Oral, 2019-2033
      • Figure 123. Latin America Analgesics Market (US$ Mn), by Parenteral, 2019-2033
      • Figure 124. Latin America Analgesics Market (US$ Mn), by Transdermal, 2019-2033
      • Figure 125. Latin America Analgesics Market (US$ Mn), by Others, 2019-2033
      • Figure 126. Latin America Analgesics Market Analysis, By Distribution Channel, 2019, 2023 and 2033
      • Figure 127. Latin America Analgesics Market Attractiveness Analysis, By Distribution Channel
      • Figure 128. Latin America Analgesics Market (US$ Mn), by Hospital pharmacies, 2019-2033
      • Figure 129. Latin America Analgesics Market (US$ Mn), by Retail pharmacies, 2019-2033
      • Figure 130. Latin America Analgesics Market (US$ Mn), by Online pharmacies, 2019-2033
      • Figure 131. Latin America Analgesics Market Analysis, By Country, 2019, 2023 and 2033
      • Figure 132. Latin America Analgesics Market Attractiveness Analysis, By Country
      • Figure 133. Middle East & Africa Analgesics Market Analysis, By Drug Class, 2019, 2023 and 2033
      • Figure 134. Middle East & Africa Analgesics Market Attractiveness Analysis, By Drug Class
      • Figure 135. Middle East & Africa Analgesics Market (US$ Mn), by Opioids, 2019-2033
      • Figure 136. Middle East & Africa Analgesics Market (US$ Mn), by NSAIDs, 2019-2033
      • Figure 137. Middle East & Africa Analgesics Market (US$ Mn), by Local Anesthetics, 2019-2033
      • Figure 138. Middle East & Africa Analgesics Market (US$ Mn), by Acetaminophen, 2019-2033
      • Figure 139. Middle East & Africa Analgesics Market Analysis, By Type, 2019, 2023 and 2033
      • Figure 140. Middle East & Africa Analgesics Market Attractiveness Analysis, By Type
      • Figure 141. Middle East & Africa Analgesics Market (US$ Mn), by Prescription, 2019-2033
      • Figure 142. Middle East & Africa Analgesics Market (US$ Mn), by OTC, 2019-2033
      • Figure 143. Middle East & Africa Analgesics Market Analysis, By Indication, 2019, 2023 and 2033
      • Figure 144. Middle East & Africa Analgesics Market Attractiveness Analysis, By Indication
      • Figure 145. Middle East & Africa Analgesics Market (US$ Mn), by Surgical Pain, 2019-2033
      • Figure 146. Middle East & Africa Analgesics Market (US$ Mn), by Cancer Pain, 2019-2033
      • Figure 147. Middle East & Africa Analgesics Market (US$ Mn), by Neuropathic Pain, 2019-2033
      • Figure 148. Middle East & Africa Analgesics Market (US$ Mn), by Others, 2019-2033
      • Figure 149. Middle East & Africa Analgesics Market Analysis, By Route of Administration, 2019, 2023 and 2033
      • Figure 150. Middle East & Africa Analgesics Market Attractiveness Analysis, By Route of Administration
      • Figure 151. Middle East & Africa Analgesics Market (US$ Mn), by Oral, 2019-2033
      • Figure 152. Middle East & Africa Analgesics Market (US$ Mn), by Parenteral, 2019-2033
      • Figure 153. Middle East & Africa Analgesics Market (US$ Mn), by Transdermal, 2019-2033
      • Figure 154. Middle East & Africa Analgesics Market (US$ Mn), by Others, 2019-2033
      • Figure 155. Middle East & Africa Analgesics Market Analysis, By Distribution Channel, 2019, 2023 and 2033
      • Figure 156. Middle East & Africa Analgesics Market Attractiveness Analysis, By Distribution Channel
      • Figure 157. Middle East & Africa Analgesics Market (US$ Mn), by Hospital pharmacies, 2019-2033
      • Figure 158. Middle East & Africa Analgesics Market (US$ Mn), by Retail pharmacies, 2019-2033
      • Figure 159. Middle East & Africa Analgesics Market (US$ Mn), by Online pharmacies, 2019-2033
      • Figure 160. Middle East & Africa Analgesics Market Analysis, By Country, 2019, 2023 and 2033
      • Figure 161. Middle East & Africa Analgesics Market Attractiveness Analysis, By Country
  • settingsSettings

Related Reports

Our Clients

  • Our Clients
Inquiry Before Buying

Analgesics Market
  • 134003
  • Nov 2024
    • ★★★★★
      ★★★★★
    • (142)
add_shopping_cart Buy Now
Trusted by more than 17382 organizations globally
  • Client Logo
  • Client Logo
  • Client Logo
✖
Request a Sample Report
We'll get back to you as quickly as possible

Single User
$6,000
$3,999
USD / per unit
save 24%
Multi User
$8,000
$5,999
USD / per unit
save 28%
Corporate User
$10,000
$6,999
USD / per unit
save 32%
e-Access
Report Library Access
Data Set (Excel)
Print
Company Profile Library Access
Interactive Dashboard
Free Custumization No up to 10 hrs work up to 30 hrs work
Accessibility 1 User 2-5 User Unlimited
Analyst Support up to 20 hrs up to 40 hrs up to 50 hrs
Benefit Up to 20% off on next purchase Up to 25% off on next purchase Up to 30% off on next purchase
Buy Now ($ 3,999) Buy Now ($ 5,999) Buy Now ($ 6,999)
Find Help
Legal
Explore
Secured Payment Options
Secured Payment Options